ID   LECF_ALEAU              Reviewed;         313 AA.
AC   P18891;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   03-AUG-2022, entry version 84.
DE   RecName: Full=Fucose-specific lectin {ECO:0000303|PubMed:2193930};
DE   AltName: Full=Aleuria aurantia lectin {ECO:0000303|PubMed:2193930};
DE            Short=AAL {ECO:0000303|PubMed:2193930};
OS   Aleuria aurantia (Orange peel mushroom).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Pezizomycetes;
OC   Pezizales; Pyronemataceae; Aleuria.
OX   NCBI_TaxID=5188;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, AND DEVELOPMENTAL STAGE.
RX   PubMed=2193930; DOI=10.1093/oxfordjournals.jbchem.a123024;
RA   Fukumori F., Takeuchi N., Hagiwara T., Ohbayashi H., Endo T., Kochibe N.,
RA   Nagata Y., Kobata A.;
RT   "Primary structure of a fucose-specific lectin obtained from a mushroom,
RT   Aleuria aurantia.";
RL   J. Biochem. 107:190-196(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Ogawa S., Ando A., Nagata Y.;
RL   Submitted (JUN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-31, PROTEIN SEQUENCE OF 2-31, AND FUNCTION.
RX   PubMed=2666154; DOI=10.1016/0014-5793(89)80709-4;
RA   Fukumori F., Takeuchi N., Hagiwara T., Ito K., Kochibe N., Kobata A.,
RA   Nagata Y.;
RT   "Cloning and expression of a functional fucose-specific lectin from an
RT   orange peel mushroom, Aleuria aurantia.";
RL   FEBS Lett. 250:153-156(1989).
RN   [4]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=7397108; DOI=10.1021/bi00554a004;
RA   Kochibe N., Furukawa K.;
RT   "Purification and properties of a novel fucose-specific hemagglutinin of
RT   Aleuria aurantia.";
RL   Biochemistry 19:2841-2846(1980).
RN   [5]
RP   FUNCTION.
RX   PubMed=17383961; DOI=10.1074/jbc.m701195200;
RA   Matsumura K., Higashida K., Ishida H., Hata Y., Yamamoto K., Shigeta M.,
RA   Mizuno-Horikawa Y., Wang X., Miyoshi E., Gu J., Taniguchi N.;
RT   "Carbohydrate binding specificity of a fucose-specific lectin from
RT   Aspergillus oryzae: a novel probe for core fucose.";
RL   J. Biol. Chem. 282:15700-15708(2007).
RN   [6]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=18493851; DOI=10.1007/s10719-008-9135-7;
RA   Olausson J., Tibell L., Jonsson B.H., Paahlsson P.;
RT   "Detection of a high affinity binding site in recombinant Aleuria aurantia
RT   lectin.";
RL   Glycoconj. J. 25:753-762(2008).
RN   [7]
RP   FUNCTION.
RX   PubMed=19109923; DOI=10.1016/j.ab.2008.11.044;
RA   Matsumura K., Higashida K., Hata Y., Kominami J., Nakamura-Tsuruta S.,
RA   Hirabayashi J.;
RT   "Comparative analysis of oligosaccharide specificities of fucose-specific
RT   lectins from Aspergillus oryzae and Aleuria aurantia using frontal affinity
RT   chromatography.";
RL   Anal. Biochem. 386:217-221(2009).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF ASN-225.
RX   PubMed=21945439; DOI=10.1016/j.bbrc.2011.09.027;
RA   Romano P.R., Mackay A., Vong M., DeSa J., Lamontagne A., Comunale M.A.,
RA   Hafner J., Block T., Lec R., Mehta A.;
RT   "Development of recombinant Aleuria aurantia lectins with altered binding
RT   specificities to fucosylated glycans.";
RL   Biochem. Biophys. Res. Commun. 414:84-89(2011).
RN   [9]
RP   SUBUNIT, MUTAGENESIS OF TYR-7 AND SER-284, AND FUNCTION.
RX   PubMed=20798114; DOI=10.1093/glycob/cwq129;
RA   Olausson J., Astroem E., Jonsson B.H., Tibell L.A., Paahlsson P.;
RT   "Production and characterization of a monomeric form and a single-site form
RT   of Aleuria aurantia lectin.";
RL   Glycobiology 21:34-44(2011).
RN   [10]
RP   FUNCTION.
RX   PubMed=22738968; DOI=10.1271/bbb.110982;
RA   Amano K., Katayama H., Saito A., Ando A., Nagata Y.;
RT   "Aleuria aurantia lectin exhibits antifungal activity against Mucor
RT   racemosus.";
RL   Biosci. Biotechnol. Biochem. 76:967-970(2012).
RN   [11]
RP   FUNCTION.
RX   PubMed=22226468; DOI=10.1016/j.jchromb.2011.12.015;
RA   Bergstroem M., Astroem E., Paahlsson P., Ohlson S.;
RT   "Elucidating the selectivity of recombinant forms of Aleuria aurantia
RT   lectin using weak affinity chromatography.";
RL   J. Chromatogr. B 885:66-72(2012).
RN   [12]
RP   BIOTECHNOLOGY.
RX   PubMed=22789673; DOI=10.1016/j.jprot.2012.06.027;
RA   Ahn Y.H., Shin P.M., Oh N.R., Park G.W., Kim H., Yoo J.S.;
RT   "A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform
RT   for identification of multiple liver cancer biomarkers in human plasma.";
RL   J. Proteomics 75:5507-5515(2012).
RN   [13]
RP   BIOTECHNOLOGY.
RX   PubMed=24027776; DOI=10.1039/c3an01126g;
RA   Ahn Y.H., Shin P.M., Kim Y.S., Oh N.R., Ji E.S., Kim K.H., Lee Y.J.,
RA   Kim S.H., Yoo J.S.;
RT   "Quantitative analysis of aberrant protein glycosylation in liver cancer
RT   plasma by AAL-enrichment and MRM mass spectrometry.";
RL   Analyst 138:6454-6462(2013).
RN   [14]
RP   FUNCTION, MUTAGENESIS OF ASN-225, AND BIOTECHNOLOGY.
RX   PubMed=27650323; DOI=10.1002/pmic.201600064;
RA   Norton P., Comunale M.A., Herrera H., Wang M., Houser J., Wimmerova M.,
RA   Romano P.R., Mehta A.;
RT   "Development and application of a novel recombinant Aleuria aurantia lectin
RT   with enhanced core fucose binding for identification of glycoprotein
RT   biomarkers of hepatocellular carcinoma.";
RL   Proteomics 16:3126-3136(2016).
RN   [15]
RP   FUNCTION.
RX   PubMed=28800497; DOI=10.1016/j.carres.2017.07.011;
RA   Cai D., Xun C., Tang F., Tian X., Yang L., Ding K., Li W., Le Z., Huang W.;
RT   "Glycoconjugate probes containing a core-fucosylated N-glycan trisaccharide
RT   for fucose lectin identification and purification.";
RL   Carbohydr. Res. 449:143-152(2017).
RN   [16]
RP   BIOTECHNOLOGY.
RX   PubMed=28748044; DOI=10.1080/20002297.2017.1345581;
RA   Tawakoli P.N., Neu T.R., Busck M.M., Kuhlicke U., Schramm A., Attin T.,
RA   Wiedemeier D.B., Schlafer S.;
RT   "Visualizing the dental biofilm matrix by means of fluorescence lectin-
RT   binding analysis.";
RL   J. Oral Microbiol. 9:1345581-1345581(2017).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.24 ANGSTROMS) OF 2-313 IN COMPLEX WITH
RP   ALPHA-L-FUCOSE AND BETA-L-FUCOSE, FUNCTION, AND DOMAIN.
RX   PubMed=14503859; DOI=10.1021/bi034983z;
RA   Fujihashi M., Peapus D.H., Kamiya N., Nagata Y., Miki K.;
RT   "Crystal structure of fucose-specific lectin from Aleuria aurantia binding
RT   ligands at three of its five sugar recognition sites.";
RL   Biochemistry 42:11093-11099(2003).
RN   [18] {ECO:0007744|PDB:1OFZ}
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 2-313 IN COMPLEX WITH
RP   ALPHA-L-FUCOSE AND BETA-L-FUCOSE, FUNCTION, AND DOMAIN.
RX   PubMed=12732625; DOI=10.1074/jbc.m302642200;
RA   Wimmerova M., Mitchell E., Sanchez J.F., Gautier C., Imberty A.;
RT   "Crystal structure of fungal lectin: six-bladed beta-propeller fold and
RT   novel fucose recognition mode for Aleuria aurantia lectin.";
RL   J. Biol. Chem. 278:27059-27067(2003).
CC   -!- FUNCTION: Lectin that specifically binds to L-fucose (PubMed:2193930,
CC       PubMed:2666154, PubMed:7397108, PubMed:18493851, PubMed:21945439,
CC       PubMed:27650323, PubMed:28800497, PubMed:14503859, PubMed:12732625).
CC       Has strongest preference for the alpha-1,6-fucosylated chain (core
CC       fucose) on glycoproteins among alpha-1,2-, alpha-1,3-, alpha-1,4-, and
CC       alpha-1,6-fucosylated chains (PubMed:17383961, PubMed:19109923,
CC       PubMed:20798114, PubMed:22226468). Might play a role in the
CC       differentiation of the fruiting body (PubMed:2193930). Exhibits
CC       antifungal activity against Mucor racemosus and thus could act as an
CC       antifungal protein in natural ecosystems (PubMed:22738968).
CC       {ECO:0000269|PubMed:12732625, ECO:0000269|PubMed:14503859,
CC       ECO:0000269|PubMed:17383961, ECO:0000269|PubMed:18493851,
CC       ECO:0000269|PubMed:19109923, ECO:0000269|PubMed:20798114,
CC       ECO:0000269|PubMed:2193930, ECO:0000269|PubMed:21945439,
CC       ECO:0000269|PubMed:22226468, ECO:0000269|PubMed:22738968,
CC       ECO:0000269|PubMed:2666154, ECO:0000269|PubMed:27650323,
CC       ECO:0000269|PubMed:28800497, ECO:0000269|PubMed:7397108}.
CC   -!- SUBUNIT: Forms homodimers (PubMed:2193930, PubMed:7397108,
CC       PubMed:20798114, PubMed:12732625). The two AAL monomers are associated
CC       via interactions between N-terminal and C-terminal peptides
CC       (PubMed:12732625). Tyr-7 interacts via aromatic ring stacking with its
CC       counterpart on the other monomer, whereas Ser-284 interacts via
CC       hydrogen bonding with Asp-264 on the other monomer (PubMed:12732625).
CC       {ECO:0000269|PubMed:12732625, ECO:0000269|PubMed:20798114,
CC       ECO:0000269|PubMed:2193930, ECO:0000269|PubMed:7397108}.
CC   -!- DEVELOPMENTAL STAGE: AAL is detected in fruiting bodies but not in
CC       mycelia (PubMed:2193930). {ECO:0000269|PubMed:2193930}.
CC   -!- DOMAIN: AAL adopts the six-bladed beta-propeller fold and contains 5
CC       binding sites per monomer, each located between two adjacent blades
CC       (PubMed:14503859, PubMed:12732625). Residues conserved at 5 of the 6
CC       sites, are located on the surface of the AAL and directly contribute to
CC       fucose recognition (PubMed:14503859). Because the corresponding
CC       residues forming site 6 are not conserved, this site cannot be
CC       considered to accommodate fucose molecules (PubMed:14503859). The 5
CC       binding sites that are non-equivalent, and owing to minor differences
CC       in amino-acid composition they exhibit a marked difference in specific
CC       ligand recognition (PubMed:18493851, PubMed:12732625).
CC       {ECO:0000269|PubMed:12732625, ECO:0000269|PubMed:14503859,
CC       ECO:0000269|PubMed:18493851}.
CC   -!- BIOTECHNOLOGY: AAL's binding activity could be used to identify
CC       secreted fucosylated glycoproteins that may represent candidate
CC       biomarkers for cancer since fucosylation of N-linked glycans has been
CC       associated with several types of cancer such as liver cancer
CC       (PubMed:22789673, PubMed:24027776, PubMed:27650323). Identified as one
CC       of the several suitable fluorescently labeled lectins that can be used
CC       in a combination for the visualization and quantification of
CC       extracellular glycoconjugates in dental supragingival biofilms grown
CC       for 48 hours in situ in the absence of dietary carbohydrates
CC       (PubMed:28748044). {ECO:0000269|PubMed:22789673,
CC       ECO:0000269|PubMed:24027776, ECO:0000269|PubMed:27650323,
CC       ECO:0000269|PubMed:28748044}.
CC   -!- SIMILARITY: Belongs to the fungal fucose-specific lectin family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D00573; BAA00451.1; -; mRNA.
DR   EMBL; D85776; BAA12871.1; -; Genomic_DNA.
DR   PIR; JX0096; JX0096.
DR   PDB; 1IUB; X-ray; 2.31 A; A=2-313.
DR   PDB; 1IUC; X-ray; 2.24 A; A=2-313.
DR   PDB; 1OFZ; X-ray; 1.50 A; A/B=2-313.
DR   PDB; 5MXC; X-ray; 1.14 A; A=1-313.
DR   PDB; 6GKE; X-ray; 1.08 A; A=2-313.
DR   PDBsum; 1IUB; -.
DR   PDBsum; 1IUC; -.
DR   PDBsum; 1OFZ; -.
DR   PDBsum; 5MXC; -.
DR   PDBsum; 6GKE; -.
DR   AlphaFoldDB; P18891; -.
DR   SMR; P18891; -.
DR   UniLectin; P18891; -.
DR   EvolutionaryTrace; P18891; -.
DR   GO; GO:0030246; F:carbohydrate binding; IDA:UniProtKB.
DR   GO; GO:0042806; F:fucose binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0050832; P:defense response to fungus; IDA:UniProtKB.
DR   GO; GO:0030582; P:reproductive fruiting body development; IEP:UniProtKB.
DR   InterPro; IPR012475; Fungal_lectin.
DR   Pfam; PF07938; Fungal_lectin; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Fruiting body; Lectin; Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:2666154"
FT   CHAIN           2..313
FT                   /note="Fucose-specific lectin"
FT                   /id="PRO_0000084401"
FT   REPEAT          5..57
FT                   /note="1"
FT                   /evidence="ECO:0000305|PubMed:12732625,
FT                   ECO:0000305|PubMed:14503859, ECO:0000305|PubMed:2193930"
FT   REPEAT          58..109
FT                   /note="2"
FT                   /evidence="ECO:0000305|PubMed:12732625,
FT                   ECO:0000305|PubMed:14503859, ECO:0000305|PubMed:2193930"
FT   REPEAT          110..162
FT                   /note="3"
FT                   /evidence="ECO:0000305|PubMed:12732625,
FT                   ECO:0000305|PubMed:14503859, ECO:0000305|PubMed:2193930"
FT   REPEAT          163..208
FT                   /note="4"
FT                   /evidence="ECO:0000305|PubMed:12732625,
FT                   ECO:0000305|PubMed:14503859, ECO:0000305|PubMed:2193930"
FT   REPEAT          209..260
FT                   /note="5"
FT                   /evidence="ECO:0000305|PubMed:12732625,
FT                   ECO:0000305|PubMed:14503859, ECO:0000305|PubMed:2193930"
FT   REPEAT          261..304
FT                   /note="6"
FT                   /evidence="ECO:0000305|PubMed:12732625,
FT                   ECO:0000305|PubMed:14503859, ECO:0000305|PubMed:2193930"
FT   REGION          5..304
FT                   /note="6 X approximate tandem repeats"
FT                   /evidence="ECO:0000305|PubMed:12732625,
FT                   ECO:0000305|PubMed:14503859, ECO:0000305|PubMed:2193930"
FT   BINDING         25
FT                   /ligand="beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42589"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0000269|PubMed:14503859, ECO:0007744|PDB:1IUC,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         37
FT                   /ligand="beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42589"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0000269|PubMed:14503859, ECO:0007744|PDB:1IUC,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         78
FT                   /ligand="alpha-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         78
FT                   /ligand="beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42589"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0000269|PubMed:14503859, ECO:0007744|PDB:1IUC,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         90
FT                   /ligand="alpha-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         90
FT                   /ligand="beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42589"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0000269|PubMed:14503859, ECO:0007744|PDB:1IUC,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         98
FT                   /ligand="beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42589"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0000269|PubMed:14503859, ECO:0007744|PDB:1IUC,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         102
FT                   /ligand="alpha-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         102
FT                   /ligand="beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42589"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0000269|PubMed:14503859, ECO:0007744|PDB:1IUB,
FT                   ECO:0007744|PDB:1IUC, ECO:0007744|PDB:1OFZ"
FT   BINDING         132
FT                   /ligand="beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42589"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         147
FT                   /ligand="beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42589"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         154
FT                   /ligand="alpha-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         154
FT                   /ligand="beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42589"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0000269|PubMed:14503859, ECO:0007744|PDB:1IUC,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         180
FT                   /ligand="alpha-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0000269|PubMed:14503859, ECO:0007744|PDB:1IUC,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         192
FT                   /ligand="alpha-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0000269|PubMed:14503859, ECO:0007744|PDB:1IUC,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         200
FT                   /ligand="beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42589"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         204
FT                   /ligand="alpha-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0000269|PubMed:14503859, ECO:0007744|PDB:1IUC,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         227
FT                   /ligand="beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42589"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         239
FT                   /ligand="beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42589"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         246
FT                   /ligand="alpha-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0000269|PubMed:14503859, ECO:0007744|PDB:1IUC,
FT                   ECO:0007744|PDB:1OFZ"
FT   BINDING         299
FT                   /ligand="beta-L-fucose"
FT                   /ligand_id="ChEBI:CHEBI:42589"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000269|PubMed:12732625,
FT                   ECO:0007744|PDB:1OFZ"
FT   MUTAGEN         7
FT                   /note="Y->R: Impairs homodimerization."
FT                   /evidence="ECO:0000269|PubMed:20798114"
FT   MUTAGEN         225
FT                   /note="N->Q: Leads to increased binding to fucosylated
FT                   glycans."
FT                   /evidence="ECO:0000269|PubMed:21945439,
FT                   ECO:0000269|PubMed:27650323"
FT   MUTAGEN         284
FT                   /note="S->D: Impairs homodimerization."
FT                   /evidence="ECO:0000269|PubMed:20798114"
FT   STRAND          11..16
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          23..30
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          33..41
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   HELIX           51..53
FT                   /evidence="ECO:0007829|PDB:1OFZ"
FT   STRAND          54..57
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          65..71
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          74..82
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          87..96
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          98..100
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   HELIX           102..106
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          117..122
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          124..127
FT                   /evidence="ECO:0007829|PDB:1IUC"
FT   STRAND          130..135
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          143..164
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          169..175
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          178..185
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          188..198
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          200..202
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          214..220
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   TURN            221..224
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          225..231
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          237..246
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          250..252
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          268..272
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   TURN            273..275
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          276..283
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   TURN            284..286
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          287..294
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   TURN            295..297
FT                   /evidence="ECO:0007829|PDB:6GKE"
FT   STRAND          298..301
FT                   /evidence="ECO:0007829|PDB:6GKE"
SQ   SEQUENCE   313 AA;  33529 MW;  06839A365AA0CAE5 CRC64;
     MPTEFLYTSK IAAISWAATG GRQQRVYFQD LNGKIREAQR GGDNPWTGGS SQNVIGEAKL
     FSPLAAVTWK SAQGIQIRVY CVNKDNILSE FVYDGSKWIT GQLGSVGVKV GSNSKLAALQ
     WGGSESAPPN IRVYYQKSNG SGSSIHEYVW SGKWTAGASF GSTVPGTGIG ATAIGPGRLR
     IYYQATDNKI REHCWDSNSW YVGGFSASAS AGVSIAAISW GSTPNIRVYW QKGREELYEA
     AYGGSWNTPG QIKDASRPTP SLPDTFIAAN SSGNIDISVF FQASGVSLQQ WQWISGKGWS
     IGAVVPTGTP AGW
//
